These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6808306)

  • 21. GM1 and GM2 gangliosides: recent developments.
    Bisel B; Pavone FS; Calamai M
    Biomol Concepts; 2014 Mar; 5(1):87-93. PubMed ID: 25372744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphology of the gangliosidoses.
    Goebel HH
    Neuropediatrics; 1984 Sep; 15 Suppl():97-106. PubMed ID: 6100800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assay of the GM2-ganglioside cleaving hexosaminidase activity of skin fibroblasts for GM2-gangliosidoses.
    Harzer K
    Clin Chim Acta; 1983 Nov; 135(1):89-93. PubMed ID: 6228344
    [No Abstract]   [Full Text] [Related]  

  • 24. Neurophysiological investigations in GM1 and GM2 gangliosidoses.
    Pampiglione G; Harden A
    Neuropediatrics; 1984 Sep; 15 Suppl():74-84. PubMed ID: 6100798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A fluorometric method for monitoring the enzymic hydrolysis of terminal galactose from GM1-ganglioside.
    Yeung KK; Owen AJ; Dain JA
    Anal Biochem; 1979 Apr; 94(1):186-92. PubMed ID: 223469
    [No Abstract]   [Full Text] [Related]  

  • 26. Lysosomal enzyme precursors in human fibroblasts. Activation of cathepsin D precursor in vitro and activity of beta-hexosaminidase A precursor towards ganglioside GM2.
    Hasilik A; von Figura K; Conzelmann E; Nehrkorn H; Sandhoff K
    Eur J Biochem; 1982 Jul; 125(2):317-21. PubMed ID: 6214395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The degradative pathway of gangliosides GM1 and GM2 in Neuro2a cells by sialidase.
    Riboni L; Caminiti A; Bassi R; Tettamanti G
    J Neurochem; 1995 Jan; 64(1):451-4. PubMed ID: 7798945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deficiency of the hexosaminidase A activator protein in a case of GM2 gangliosidosis; variant AB.
    Hechtman P; Gordon BA; Ng Ying Kin NM
    Pediatr Res; 1982 Mar; 16(3):217-22. PubMed ID: 6801612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The N-acetylgalactosamine residue of exogenous GM2 ganglioside is recycled for glycoconjugate biosynthesis in rat liver.
    Trinchera M; Ghidoni R; Greggia L; Tettamanti G
    Biochem J; 1990 Feb; 266(1):103-6. PubMed ID: 2310367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substrate binding properties of the human liver hexosaminidase A activator protein.
    Hechtman P; Isaacs C; Smith-Jones L
    Can J Biochem Cell Biol; 1985 Aug; 63(8):830-8. PubMed ID: 2933135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis of Tay-Sachs disease using [3H]N-acetylneuraminic acid labelled GM2 ganglioside as substrate.
    Poulos A; Holding J; Carey WF
    Clin Chim Acta; 1982 Apr; 120(3):331-40. PubMed ID: 6210469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
    Charrow J; Binns HJ
    Clin Chim Acta; 1986 Apr; 156(1):41-9. PubMed ID: 2938852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assay of ganglioside GM2-N-acetyl-beta-D-galactosaminidase activity in human fibroblasts employing the natural activator protein--diagnosis of variant forms of GM2 gangliosidosis.
    Erzberger A; Conzelmann E; Sandhoff K
    Clin Chim Acta; 1980 Dec; 108(3):361-8. PubMed ID: 6781795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GM1-gangliosidosis: accumulation of ganglioside GM1 in cultured skin fibroblasts and correlation with clinical types.
    Suzuki Y; Nakamura N; Fukuoka K
    Hum Genet; 1978 Aug; 43(2):127-31. PubMed ID: 99363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetics of rat liver GM2 ganglioside-beta-D-N-acetylhexosaminidase.
    Novak A; Lowden JA
    Can J Biochem; 1980 Jan; 58(1):82-8. PubMed ID: 6446371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activator proteins for lysosomal glycolipid hydrolysis.
    Conzelmann E; Sandhoff K
    Methods Enzymol; 1987; 138():792-815. PubMed ID: 2885714
    [No Abstract]   [Full Text] [Related]  

  • 37. [Function and relevance of activator proteins for glycolipid degradation].
    Sandhoff K
    Seikagaku; 1985 Feb; 57(2):87-102. PubMed ID: 3925052
    [No Abstract]   [Full Text] [Related]  

  • 38. Precursor-product relationship between GM1 and GD1a biosynthesized from exogenous GM2 ganglioside in rat liver.
    Trinchera M; Ghidoni R
    J Biochem; 1990 Apr; 107(4):619-23. PubMed ID: 2358435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gangliosides of liver tumors induced by N-2-fluorenylacetamide. I. Ganglioside alterations in liver tumorigenesis and normal development.
    Merritt WD; Richardson CL; Keenan TW; Morré DJ
    J Natl Cancer Inst; 1978 Jun; 60(6):1313-27. PubMed ID: 206706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Activator protein for the enzymic hydrolysis of sphingolipids and their relationships to sphingolipidosis. Special reference to the catabolism of GM2 ganglioside].
    Hirabayashi Y; Li YT; Li SC
    Seikagaku; 1983; 55(1):1-13. PubMed ID: 6405000
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.